Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly - Reuters

Reuters | Oct. 10, 2025, 11:47 a.m. | Original
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly Reuters
Brazil's trading firm Timbro enters coffee export market as it sees room to grow - Reuters News by Acceswire on TradingView, 2025-10-10 - TradingView